«The Israel-based startup announced the closing of its $33 million funding from investors, including Yozma Group Korea and Ubicom Holdings Japan. The company did not provide the other investors’ detail.
The company will use the latest funding to support illumigyn’s research and development, which focuses on turning illumigyn into a comprehensive solution for examining the lower genital tract.»
Article written by Kate Park. Photo by illumigyn.